Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / Companies / Agilent Technologies — Dako Omnis
Entity

Agilent Technologies — Dako Omnis

Tracked across 1 events · 7 articles · First seen Jun 02, 2026 · Last active Jun 02, 2026

Sentiment
70
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 70
Regulatory
FDA Approves Agilent PD-L1 Test
The United States — Food and Drug Administration has approved the expanded use of General Atomics' PD-L1 IHC 22C3 pharmDx, Code GE006, on the Agilent Technologies — Dako Omnis platform. This approval allows the diagnostic…
Impact: The Agilent Technologies — Dako Omnis platform is now approved for expanded use of PD-L1 IHC 22C3 pharmDx, allowing pathology laboratories to consolidate testing and improve efficiency.
Jun 02, 2026 · 7 articles
NEWSDESK
Track Agilent Technologies — Dako Omnis live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.